242 related articles for article (PubMed ID: 2867214)
1. Effects of fenoldopam on regional vascular resistance in conscious spontaneously hypertensive rats.
Lappe RW; Todt JA; Wendt RL
J Pharmacol Exp Ther; 1986 Jan; 236(1):187-91. PubMed ID: 2867214
[TBL] [Abstract][Full Text] [Related]
2. Preferential renal vasodilator effects of CGP 22979A in conscious spontaneously hypertensive rats.
Smits JF; Struyker-Boudier HA
J Pharmacol Exp Ther; 1985 Mar; 232(3):845-9. PubMed ID: 3973832
[TBL] [Abstract][Full Text] [Related]
3. Selective central alpha-2 adrenoceptor control of regional haemodynamic responses to air jet stress in conscious spontaneously hypertensive rats.
Kapusta DR; Knardahl S; Koepke JP; Johnson AK; DiBona GF
J Hypertens; 1989 Mar; 7(3):189-94. PubMed ID: 2540234
[TBL] [Abstract][Full Text] [Related]
4. Graded regional vasodilation with converting enzyme inhibitors in conscious spontaneously hypertensive rats.
Lappe RW; Todt JA; Wendt RL
J Pharmacol Exp Ther; 1985 Dec; 235(3):651-6. PubMed ID: 3001271
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular effects of adenosine A2 agonists in the conscious spontaneously hypertensive rat: a comparative study of three structurally distinct ligands.
Webb RL; Barclay BW; Graybill SC
J Pharmacol Exp Ther; 1991 Dec; 259(3):1203-12. PubMed ID: 1684818
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist.
Hahn RA; Wardell JR; Sarau HM; Ridley PT
J Pharmacol Exp Ther; 1982 Nov; 223(2):305-13. PubMed ID: 6127401
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of the novel inotropic agent, ibopamine, with epinine, dopamine and fenoldopam on renal vascular dopamine receptors in the anesthetized dog.
Nichols AJ; Smith JM; Shebuski RJ; Ruffolo RR
J Pharmacol Exp Ther; 1987 Aug; 242(2):573-8. PubMed ID: 2886644
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular effects of rat calcitonin gene-related peptide in the conscious rat.
Sirén AL; Feuerstein G
J Pharmacol Exp Ther; 1988 Oct; 247(1):69-78. PubMed ID: 2459371
[TBL] [Abstract][Full Text] [Related]
9. Hypotensive and regional hemodynamic effects of the dopamine receptor agonist SK & F 85174 in the anesthetized rat.
Van der Niepen P; Schoors DF; Dupont AG
Arch Int Pharmacodyn Ther; 1991; 313():98-107. PubMed ID: 1687774
[TBL] [Abstract][Full Text] [Related]
10. Regional hemodynamic effects of purinergic P2 receptor subtype agonists in rats.
Cox BF; Smits GJ
J Pharmacol Exp Ther; 1996 Jun; 277(3):1492-500. PubMed ID: 8667215
[TBL] [Abstract][Full Text] [Related]
11. Suppression of sympathetic ganglionic neurotransmission by the selective dopamine-1 receptor agonist fenoldopam (SK&F 82526) in the anesthetized dog.
Shebuski RJ; Fujita T; Smith JM; Kopaciewicz LJ; Blumberg AL; Hieble JP
J Pharmacol Exp Ther; 1985 Dec; 235(3):735-40. PubMed ID: 2867207
[TBL] [Abstract][Full Text] [Related]
12. Effects of the dual metallopeptidase inhibitor, MDL 100,240, on regional haemodynamic responses to vasoactive peptides in conscious rats.
Gardiner SM; Kemp PA; Brunner-Ferber F; Bennett T
Br J Pharmacol; 1997 Dec; 122(8):1687-93. PubMed ID: 9422815
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats.
Cavero I; Lefevre-Borg F; Lhoste F; Sabatier C; Richer C; Giudicelli JF
J Pharmacol Exp Ther; 1984 Mar; 228(3):779-91. PubMed ID: 6707926
[TBL] [Abstract][Full Text] [Related]
14. Studies on the mechanisms of the development of tolerance to the hypotensive effects of fenoldopam in rats.
Lefèvre-Borg F; Lorrain J; Lechaire J; Thiry C; Hicks PE; Cavero I
J Cardiovasc Pharmacol; 1988 Apr; 11(4):444-55. PubMed ID: 2453748
[TBL] [Abstract][Full Text] [Related]
15. Adrenergic mechanisms underlying cardiac and vascular responses to cocaine in conscious rats.
Branch CA; Knuepfer MM
J Pharmacol Exp Ther; 1992 Nov; 263(2):742-51. PubMed ID: 1359113
[TBL] [Abstract][Full Text] [Related]
16. L-649,923: an antagonist of cardiac and vascular leukotriene D4 receptors.
Sirén AL; Eimerl J; Feuerstein G
J Cardiovasc Pharmacol; 1989 Feb; 13(2):210-7. PubMed ID: 2468948
[TBL] [Abstract][Full Text] [Related]
17. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
[TBL] [Abstract][Full Text] [Related]
18. Regional vascular effects of MPC-1304, a novel dihydropyridine derivative, in conscious normotensive and spontaneously hypertensive rats.
Miyoshi K; Kanda A; Nozawa Y; Nakano M; Miyake H
J Pharmacol Exp Ther; 1996 Jun; 277(3):1328-36. PubMed ID: 8667194
[TBL] [Abstract][Full Text] [Related]
19. Selective peripheral dopamine-1 receptor stimulation with fenoldopam in human essential hypertension.
Carey RM; Stote RM; Dubb JW; Townsend LH; Rose CE; Kaiser DL
J Clin Invest; 1984 Dec; 74(6):2198-207. PubMed ID: 6150942
[TBL] [Abstract][Full Text] [Related]
20. Dopaminergic receptor-mediated effects in the mesenteric vasculature and renal vasculature of the chronically instrumented newborn piglet.
Pearson RJ; Barrington KJ; Jirsch DW; Cheung PY
Crit Care Med; 1996 Oct; 24(10):1706-12. PubMed ID: 8874310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
